Concepedia

Publication | Closed Access

Noninferiority of Inhaled Epoprostenol to Inhaled Nitric Oxide for the Treatment of ARDS

DOI

36

Citations

20

References

2015

Year

Mahmoud Ammar, Seth R. Bauer, Stephanie Bass, Madhu Sasidhar, Rory Mullin, Simon W. Lam
Annals of Pharmacotherapy

Abstract

Inhaled epoprostenol was noninferior to inhaled nitric oxide with regard to ventilator-free days from day 1 to day 28 in ARDS patients.

References

YearCitations

Page 1